192 related articles for article (PubMed ID: 28581409)
1. Current Status of Targeted Radioprotection and Radiation Injury Mitigation and Treatment Agents: A Critical Review of the Literature.
Kalman NS; Zhao SS; Anscher MS; Urdaneta AI
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):662-682. PubMed ID: 28581409
[TBL] [Abstract][Full Text] [Related]
2. Appraisal of mechanisms of radioprotection and therapeutic approaches of radiation countermeasures.
Mishra KN; Moftah BA; Alsbeih GA
Biomed Pharmacother; 2018 Oct; 106():610-617. PubMed ID: 29990850
[TBL] [Abstract][Full Text] [Related]
3. Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters.
Yahyapour R; Shabeeb D; Cheki M; Musa AE; Farhood B; Rezaeyan A; Amini P; Fallah H; Najafi M
Curr Mol Pharmacol; 2018; 11(4):285-304. PubMed ID: 29921213
[TBL] [Abstract][Full Text] [Related]
4. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury.
Moulder JE; Cohen EP
Semin Radiat Oncol; 2007 Apr; 17(2):141-8. PubMed ID: 17395044
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cardiac radiation injury and potential preventive approaches.
Slezak J; Kura B; Ravingerová T; Tribulova N; Okruhlicova L; Barancik M
Can J Physiol Pharmacol; 2015 Sep; 93(9):737-53. PubMed ID: 26030720
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic approaches to radiation protection.
Brizel DM
J Clin Oncol; 2007 Sep; 25(26):4084-9. PubMed ID: 17827457
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy and cell therapy for the management of radiation damages to healthy tissues: Rationale and early results.
Khalifa J; François S; Rancoule C; Riccobono D; Magné N; Drouet M; Chargari C
Cancer Radiother; 2019 Sep; 23(5):449-465. PubMed ID: 31400956
[TBL] [Abstract][Full Text] [Related]
8. Radioprotective agents for radiation therapy: future trends.
Johnke RM; Sattler JA; Allison RR
Future Oncol; 2014 Dec; 10(15):2345-57. PubMed ID: 25525844
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications.
Zhao W; Robbins ME
Curr Med Chem; 2009; 16(2):130-43. PubMed ID: 19149566
[TBL] [Abstract][Full Text] [Related]
10. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
[TBL] [Abstract][Full Text] [Related]
11. Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization.
Mortezaee K; Shabeeb D; Musa AE; Najafi M; Farhood B
Curr Clin Pharmacol; 2019; 14(1):41-53. PubMed ID: 30360725
[TBL] [Abstract][Full Text] [Related]
12. Research progress in the radioprotective effect of superoxide dismutase.
Huang XJ; Song CX; Zhong CQ; Wang FS
Drug Discov Ther; 2012 Aug; 6(4):169-77. PubMed ID: 23006987
[TBL] [Abstract][Full Text] [Related]
13. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis.
Delanian S; Lefaix JL
Semin Radiat Oncol; 2007 Apr; 17(2):99-107. PubMed ID: 17395040
[TBL] [Abstract][Full Text] [Related]
14. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
15. [Modern possibilities of medicinal prophylaxis and early therapy of radiation injuries].
Grebeniuk AN; Zatsepin VV; Nazarov VB; Vlasenko TN
Voen Med Zh; 2011 Feb; 332(2):13-7. PubMed ID: 21770338
[TBL] [Abstract][Full Text] [Related]
16. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation.
Zivkovic Radojevic M; Milosavljevic N; Miladinovic TB; Janković S; Folic M
Int J Radiat Biol; 2023; 99(4):594-603. PubMed ID: 35930681
[TBL] [Abstract][Full Text] [Related]
17. Utilization of cytogenetic biomarkers as a tool for assessment of radiation injury and evaluation of radiomodulatory effects of various medicinal plants - a review.
Samarth RM; Samarth M; Matsumoto Y
Drug Des Devel Ther; 2015; 9():5355-72. PubMed ID: 26451089
[TBL] [Abstract][Full Text] [Related]
18. [Effects of adaptogenes on some indices of functional state of the body on occupational radiation exposure].
Legeza VI; Astrov VV
Aviakosm Ekolog Med; 1996; 30(6):32-7. PubMed ID: 9035795
[TBL] [Abstract][Full Text] [Related]
19. Rationale for using multiple antioxidants in protecting humans against low doses of ionizing radiation.
Prasad KN
Br J Radiol; 2005 Jun; 78(930):485-92. PubMed ID: 15900053
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol as promising natural radioprotector. A review.
Dobrzyńska MM
Rocz Panstw Zakl Hig; 2013; 64(4):255-62. PubMed ID: 24693709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
